Efficacy and tolerability of long-acting risperidone in patients previously treated with opal atypical antipsychotics

被引：0
|
作者：
Schreiner, A
Moeller, HJ
机构：
[1] Janssen Cilag Neuss, Neuss, Germany
[2] Univ Munich, Dept Psychiat, Munich, Germany
来源：
SCHIZOPHRENIA RESEARCH | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
下载
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [11] Long-Acting Risperidone and Oral Antipsychotics in Schizophrenia
    Kwatra, Shawn G.
    Batson, Nicholas E.
    Kramer, Stephen I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (23): : 2264 - 2265
  • [12] Clinical and economic impact of long-acting injectable antipsychotics in patients previously treated with short-acting oral antipsychotics
    Kheloussi, Steven
    Oberlin Jr, John
    Trauger, Madison
    Testa, Nicholas D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (10): : 1130 - 1137
  • [13] Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review
    Canas, Fernando
    Moeller, Hans-Juergen
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (05) : 683 - 697
  • [14] Risperidone long-acting injectable significantly improved efficacy and tolerability in patients with psychotic disorders previously receiving conventional oral neuroleptics
    Lex, A
    Milanova, V
    Tuma, I
    Gheorghe, M
    Moeller, HJ
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 493 - 493
  • [15] Improved efficacy and safety in Danish patients treated with risperidone long-acting injectable
    Glue, P
    Lublin, H
    Refshammer, C
    Lex, A
    Lang-Jensen, L
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S402 - S403
  • [16] Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia
    Eerdekens, M
    Van Hove, I
    Remmerie, B
    Mannaert, E
    SCHIZOPHRENIA RESEARCH, 2004, 70 (01) : 91 - 100
  • [17] Efficacy and safety of long-acting risperidone injection after switching from antipsychotics in Chinese patients
    Li, H. F.
    Gu, N. F.
    Zhou, M.
    Jia, F. J.
    Zhao, Z. H.
    Fan, J. X.
    Wang, G.
    Sun, X. L.
    Li, M.
    Zhang, J. B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S405 - S406
  • [18] Long-acting injectable risperidone safety and efficacy in patients switched from conventional depot antipsychotics
    Turner, M
    Eerdekens, M
    Jacko, M
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 305 - 305
  • [19] Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone (vol 22, pg 85, 2007)
    Schmauss, M.
    Sacchetti, E.
    Kahn, J-P
    Medori, R.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (05) : 312 - 312
  • [20] Long-Acting Risperidone and Oral Antipsychotics in Unstable Schizophrenia
    Rosenheck, Robert A.
    Krystal, John H.
    Lew, Robert
    Barnett, Paul G.
    Fiore, Louis
    Valley, Danielle
    Thwin, Soe Soe
    Vertrees, Julia E.
    Liang, Matthew H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09): : 842 - 851
12345